Advertisement

March 23, 2007 / 11:30 AM

Hi-Tech: Tentative OK on generic Dovonex

AMITYVILLE, N.Y., March 23 (UPI) -- U.S. firm Hi-Tech Pharmacal said Friday it has tentative approval to market a generic version of Warner Chilcott's topical drug Dovonex.

The Food and Drug Administration has tentatively cleared for market the company's Abbreviated New Drug Application for calcipotriene topical solution, 0.005 percent, indicated for the treatment of psoriasis of the scalp.

Advertisement

Hi-Tech estimated 2006 sales of the branded drug at $13 million, based on data from IMS Health.

The FDA's full approval must await expiration of the patent covering Dovonex, which is due to expire Dec. 29, the company said.

Topics
Food and Drug Administration

Treatment for peripheral artery disease as effective for women as men

Health News // 1 day ago

Treatment for peripheral artery disease as effective for women as men

Less invasive endovascular treatments work equally well in women as in men with peripheral artery disease, a new study found.

AI may help diagnose rare diseases years earlier

Health News // 2 days ago

AI may help diagnose rare diseases years earlier

Artificial intelligence might be able to identify patients who have rare diseases years earlier than they would typically be diagnosed, a new study says.

Higher dose of smoking cessation medication may improve results

Health News // 2 days ago

Higher dose of smoking cessation medication may improve results

Folks struggling to quit smoking might need a bump up on the dose of medication they're using to help them stop, according to new clinical trial results.

Avoiding meat may help reverse advanced liver cirrhosis

Health News // 2 days ago

Avoiding meat may help reverse advanced liver cirrhosis

Advanced liver cirrhosis can push levels of ammonia in the blood to hazardous levels, but skipping meat at mealtime can help reverse that, new research shows.

Rate of deadly STEMI heart attack falls among Americans

Health News // 2 days ago

Rate of deadly STEMI heart attack falls among Americans

Many fewer Americans are falling prey to the most dangerous form of heart attack, a new study says.

Cardiac catheterization patients may be able to skip pre-op fasting

Health News // 2 days ago

Cardiac catheterization patients may be able to skip pre-op fasting

Folks undergoing cardiac catheterization procedures to diagnose heart problems may be able to safely skip the traditional pre-op fasting that's now the norm, new research shows.

Anxiety is rising among Americans amid economic struggles, looming election

Health News // 2 days ago

Anxiety is rising among Americans amid economic struggles, looming election

A looming presidential election, continued economic struggles and the threat of gun violence have a rising number of Americans more anxious this year compared to last, a new poll finds.

U.S. maternal deaths fall in 2022, remain higher than pre-pandemic levels

Health News // 2 days ago

U.S. maternal deaths fall in 2022, remain higher than pre-pandemic levels

The number of American women who died at or soon after childbirth declined significantly in 2022, the latest government data shows, but the rate is still higher than pre-pandemic levels.

Myth that tan skin looks healthier persists for a third of young adults

Health News // 3 days ago

Myth that tan skin looks healthier persists for a third of young adults

Nearly a third of Americans (32%) think that a tan makes people look better and healthier, a dangerous beauty standard that can increase a person's risk of skin cancer, poll results show.

MRNA vaccine effective in treating glioblastoma brain cancer in small trial

Health News // 3 days ago

MRNA vaccine effective in treating glioblastoma brain cancer in small trial

An experimental cancer vaccine can quickly reprogram a person's immune system to attack glioblastoma, the most aggressive and lethal form of brain cancer, a small, preliminary study has found.

Advertisement

Advertisement

Advertisement